Mishra S, Gupta V, Mishra S, Kulshrestha H, Kumar S, Gupta V, Sachan R, Mahdi AA. Association of
acylation stimulating protein and adiponectin with metabolic risk marker in North Indian obese women.
Diabetes Metab Syndr 2019;
13:2987-2990. [PMID:
30078743 DOI:
10.1016/j.dsx.2018.07.017]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/26/2018] [Accepted: 07/29/2018] [Indexed: 02/03/2023]
Abstract
BACKGROUND
Plasma concentrations of Acylation stimulating protein (ASP) and adiponectin are associated with body weight and energy homeostasis. The purpose of this study is to describe the potential role of acylation stimulating protein and adiponectin with metabolic risk marker in North Indian obese women.
METHODS
This is a case control study. Total 520 women were recruited for the study n = 260 women with obesity (BMI>30) study group and n = 260 women without obesity (BMI<25) control group. Serum ASP and adiponectin level were determined by enzyme linked immunosorbent assay.
RESULTS
Result indicated that WC, BP, lipid profile, FPG, FPI, IR (HOMA-IR), ASP were significantly higher but adiponectin and HDL were significantly lower in women with obesity than in women without obesity. Furthermore ASP was significantly positive correlated with WC, FPG, TG, VLDL, FPI and IR, whereas the correlation of adiponectin was significantly negative correlated with WC, FPG, TG, IR, ASP and significantly positive correlated with HDL in women with obesity.
CONCLUSION
The study shows that high level of ASP and low level of Adiponectin could be a potential marker of women with obesity among metabolic syndrome.
Collapse